• Most Popular
  • Most Shared

India court declines Roche bid to stay copycat drug

Wed Mar 19, 2008 6:22am EDT

Stocks

   

NEW DELHI, March 19 (Reuters) - An Indian court on Wednesday declined to restrain Indian drug maker Cipla (CIPL.BO) from selling a cheaper generic version of Swiss Roche's (ROG.VX) lung cancer drug Tarceva, an official of the Indian firm said.

"Roche had applied for a stay. This is an interim order for not granting the stay," Amar Lulla, a joint managing director at Cipla, told Reuters after a Delhi High Court verdict.

Lulla said Cipla was selling the generic erlotinib at one third of the price charged by the Swiss firm. (Reporting by Devidutta Tripathy; Editing by Ranjit Gangadharan)



More from Reuters

Photo

Fox, Time Warner Cable ink deal to avoid blackout

NEW YORK (Reuters) - Time Warner Cable and News Corp's Fox Networks Group agreed to a brief extension of their current carriage contract late on Thursday to avoid a blackout that would have prevented 13 million U.S. homes from seeing TV shows like "The Simpsons" and "House" as well as college and NFL football games.

» More Top News
A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Global Markets
Clients work out on machines at the Bally Total Fitness facility in Arvada, Colorado June 15, 2009. REUTERS/Rick Wilking

Get real with resolutions

We make them and we break them: The secret to keeping them is to avoid the impossible dream.  Full Article 

Lifestyle